Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer.
about
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancerStathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developmentsMammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.Overexpression of SCLIP promotes growth and motility in glioblastoma cellsStathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients.The mitotic tensegrity guardian tau protects mammary epithelia from katanin-like1-induced aneuploidy.Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling.Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer.Stathmin is a highly sensitive and specific biomarker for vulvar high-grade squamous intraepithelial lesions.Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.Microtubule-associated protein tau is associated with the resistance to docetaxel in prostate cancer cell linesOverexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer.Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma.p53 and Mdm2 act synergistically to maintain cardiac homeostasis and mediate cardiomyocyte cell cycle arrest through a network of microRNAs.A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma.Oncoprotein Stathmin Modulates Sensitivity to Apoptosis in Hepatocellular Carcinoma Cells During Hepatitis C Viral Replication
P2860
Q27852937-4C5121DB-2037-463D-A92F-DED4393AA912Q28079927-202964C2-1BC6-4710-9A18-F5B0EF8C88DDQ34664059-C6CFE4EB-46E9-4831-93CC-B8E50A474A3CQ36215787-1A73226B-4F11-439C-AF75-477B2C31962FQ36355929-44C46664-4ACD-4B73-ABFF-E6DF9786C311Q37619817-69D3EE12-6F72-42AF-A761-BE85E548E74FQ38952182-43733997-E8C7-487B-9BD6-754EAB5A7936Q39160331-384F7126-E214-4DCF-8ED7-AB4CCB39C94FQ40658982-C0CDF39F-F1DB-42E6-822D-6BA635E0E9EBQ41469992-A1A5FFB9-9529-42DE-ACD5-40067CA02737Q42272645-4A651FE4-CCD4-4AA0-B3E2-33037B08A034Q46284216-A79EA9D2-C164-4BCB-A909-30EE0B41D3DDQ47172693-6797F6C4-62C3-41EF-9432-A4390C8834EBQ48343149-C8B9C6B9-ADE6-4315-B960-17AFB0A5C707Q51768727-80B0ABE2-2A5C-446D-9039-825D66C0D9BCQ52688051-F55D1152-3C4D-44E2-8F08-DEC07FD2D382Q57177206-0E678FB2-ABC8-4AFB-A87F-914F3EC4FA9C
P2860
Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Stathmin expression and its re ...... and outcome in breast cancer.
@ast
Stathmin expression and its re ...... and outcome in breast cancer.
@en
type
label
Stathmin expression and its re ...... and outcome in breast cancer.
@ast
Stathmin expression and its re ...... and outcome in breast cancer.
@en
prefLabel
Stathmin expression and its re ...... and outcome in breast cancer.
@ast
Stathmin expression and its re ...... and outcome in breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Stathmin expression and its re ...... and outcome in breast cancer.
@en
P2093
Annette M Molinaro
David L Rimm
Huan Cheng
Lyndsay N Harris
Maria T Baquero
Veronique Neumeister
P2860
P304
P356
10.1002/CNCR.27453
P407
P50
P577
2012-02-22T00:00:00Z